Clinical Trial Update: A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of LY4006896 is enrolling healthy volunteers and Parkinson disease patients to evaluate safety and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• LY4006896

Snippet

Sponsor: Eli Lilly and Company | Conditions: Parkinson Disease | Phase 1 | Status: RECRUITING